Stock News

Mckinley Capital Management Trimmed By $1.65 Million Its Enzo Biochem (ENZ) Stake; Enviva Partners, LP (EVA) Had 4 Analysts Last Week

Mckinley Capital Management Inc decreased Enzo Biochem Inc (ENZ) stake by 53.59% reported in 2017Q4 SEC filing. Mckinley Capital Management Inc sold 206,188 shares as Enzo Biochem Inc (ENZ)’s stock declined 37.33%. The Mckinley Capital Management Inc holds 178,552 shares with $1.46 million value, down from 384,740 last quarter. Enzo Biochem Inc now has $320.55 million valuation. The stock increased 1.04% or $0.07 during the last trading session, reaching $6.82. About 70,024 shares traded. Enzo Biochem, Inc. (NYSE:ENZ) has declined 37.18% since May 16, 2017 and is downtrending. It has underperformed by 48.73% the S&P500.

Among 5 analysts covering Enviva Partners (NYSE:EVA), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Enviva Partners had 12 analyst reports since November 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, February 19 report. The stock of Enviva Partners, LP (NYSE:EVA) earned “Buy” rating by RBC Capital Markets on Tuesday, June 20. The company was initiated on Friday, August 26 by Citigroup. On Friday, September 22 the stock rating was upgraded by Citigroup to “Buy”. On Tuesday, November 7 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Enviva Partners, LP (NYSE:EVA) earned “Buy” rating by RBC Capital Markets on Thursday, August 3. The company was maintained on Sunday, July 23 by RBC Capital Markets. As per Wednesday, March 8, the company rating was maintained by RBC Capital Markets. Goldman Sachs initiated the stock with “Neutral” rating in Thursday, September 22 report. The rating was initiated by Drexel Hamilton on Wednesday, June 8 with “Buy”. See Enviva Partners, LP (NYSE:EVA) latest ratings:

More notable recent Enviva Partners, LP (NYSE:EVA) news were published by: which released: “Profit With High Yield Of 9% From The Green Trend” on April 19, 2018, also with their article: “Enviva Partners’ (EVA) CEO John Keppler on Q1 2018 Results – Earnings Call Transcript” published on May 03, 2018, published: “Key Takeaways From Enviva’s Earnings Call – Q1 18” on May 08, 2018. More interesting news about Enviva Partners, LP (NYSE:EVA) were released by: and their article: “Enviva Partners (EVA) Misses Q1 EPS by 100c, Miss on Revenues” published on May 03, 2018 as well as‘s news article titled: “Research Report Identifies Altair Engineering, Safety Insurance Group, Tyler Technologies, Veracyte, Enviva Partners …” with publication date: May 01, 2018.

Enviva Partners, LP produces and supplies utility-grade wood pellets to power generators. The company has market cap of $767.23 million. Enviva Partners GP, LLC operates as the general partner of the company. It has a 38.62 P/E ratio. Enviva Partners, LP was founded in 2013 and is based in Bethesda, Maryland.

The stock decreased 1.13% or $0.33 during the last trading session, reaching $29.12. About 94,035 shares traded or 78.40% up from the average. Enviva Partners, LP (NYSE:EVA) has declined 3.58% since May 16, 2017 and is downtrending. It has underperformed by 15.13% the S&P500.

Since January 17, 2018, it had 0 insider buys, and 2 sales for $193,750 activity. Another trade for 14,000 shares valued at $108,500 was sold by RABBANI ELAZAR. WEINER BARRY W sold $85,250 worth of Enzo Biochem, Inc. (NYSE:ENZ) on Wednesday, January 17.

Mckinley Capital Management Inc increased Carlyle Group LP (NASDAQ:CG) stake by 59,191 shares to 283,676 valued at $6.50M in 2017Q4. It also upped Abbvie Inc (NYSE:ABBV) stake by 94,985 shares and now owns 333,657 shares. Tpg Specialty Lending Inc (NYSE:TSLX) was raised too.

Enzo Biochem, Inc. (NYSE:ENZ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *